Avis de sécurité sur les produits de santé

Pays

* Les informations sont disponibles en anglais seulement.

⇡ Canada

Santé Canada – Rappels et avis de sécurité

Autres ressources

• InfoVigilance sur les produits de santé
• Quoi de neuf – MedEffet Canada
• Bulletins de l’ISMP Canada
• Médicaments sécuritaires (en anglais seulement)
• Registre des médicaments et des produits de santé
• Signaler un effet secondaire
• Capsules Rx – Avis de Santé Canada (connection requise)

⇡ États-Unis

FDA – Drug Safety Podcast

Drug safety communications

⇡ France

⇡ Royaume-Uni

• Xaqua (metolazone) 5mg tablets: exercise caution when switching patients between metolazone preparations
  25 Jan 2023
  Prescribers and dispensers should use caution if switching patients between different metolazone preparations as the rate and extent of absorption of metolazone are formulation dependent. This can impact the bioavailability …
• Topical testosterone (Testogel): risk of harm to children following accidental exposure
  25 Jan 2023
  Premature puberty and genital enlargement have been reported in children who were in close physical contact with an adult using topical testosterone and who were repeatedly accidentally exposed to this medicine. To reduce th…
• Electronic Prescribing and Medicines Administration Systems: report adverse incidents on a Yellow Card
  25 Jan 2023
  We ask healthcare professionals to be vigilant to adverse incidents involving software, apps, and artificial intelligence (AI) as medical devices and to report incidents to us via the Yellow Card scheme.
• COVID-19 vaccines and medicines: updates for January 2023
  25 Jan 2023
  Recent information relating to COVID-19 vaccines and medicines that has been published since the December 2022 issue of Drug Safety Update, up to 23 January 2022.
• Letters and medicine recalls sent to healthcare professionals in December 2022
  25 Jan 2023
  A summary of recent letters and notifications sent to healthcare professionals about medicines.
• Valproate: reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be introduced in the coming months
  12 Dec 2022
  In view of data showing ongoing exposure to valproate in pregnancy, this article reminds healthcare professionals of the risks in pregnancy and the current Pregnancy Prevention Programme requirements, and provides informatio…
• COVID-19 vaccines and medicines: updates for December 2022
  12 Dec 2022
  Recent information relating to COVID-19 vaccines and medicines that has been published since the November 2022 issue of Drug Safety Update, up to 8 December 2022.
• Letters and medicine recalls sent to healthcare professionals in November 2022
  12 Dec 2022
  A summary of recent letters and notifications sent to healthcare professionals about medicines.
• Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
  29 Nov 2022
  Healthcare professionals prescribing dupilumab should be alert to the risks of ocular reactions. New onset or worsening ocular symptoms require prompt review. Referral for ophthalmological examination should be made as appro…
• Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with you
  29 Nov 2022
  The MHRA is reviewing its approach to engaging with healthcare professionals on the safety of medicines and medical devices. Through our consultation, you can provide your views and help inform our new approach.

⇡ Nouvelle-Zélande

• 22 November 2022
  22 Nov 2022
  Goserelin (Teva) 3.6mg and 10.8 mg implants and reports of issues when administering this medicine
• 8 September 2022
  8 Sep 2022
  Myocarditis and pericarditis have been reported with Nuvaxovid (Novavax COVID-19 Vaccine)
• 5 September 2022
  5 Sep 2022
  Recall of KetoSens Test Strips – batch UJ03PBXNG
• 29 August 2022
  29 Aug 2022
  Update – Possible risk of vasculitis with vildagliptin products (Galvus, Galvumet)
• 25 August 2022
  29 Aug 2022
  Abnormal uterine bleeding and oral anticoagulants (blood thinners)
• 13 July 2022
  29 Aug 2022
  Medsafe is publishing a warning that the product Nhan Sam Tuyet Lien Truy Phong Hoan should not be consumed
• 30 June 2022
  30 Jun 2022
  Accuretic found to contain nitrosamines
• 7 June 2022
  7 Jun 2022
  Typographical error in Healgen Rapid COVID-19 Antigen Self-Test (RATs) patient instruction leaflet
• 8 April 2022
  8 Apr 2022
  Reminder: Miracle Mineral Solution has dangerous and potentially life-threatening side effects
• 22 February 2022
  24 Feb 2022
  Possible risk of vasculitis with vildagliptin products (Galvus, Galvumet)

⇡ Malaisie